Skip to content

Gold Factor on Knee Joint Health and Function

CompletedNot applicableNCT05347602
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this clinical study was to determine whether gold nanoparticles (AuNP) supplement holds clinical value in improving joint health, function, and quality of life for arthritis patients.

Study details

Official title
A Clinical Study to Evaluate the Safety and Efficacy of Microscopic Doses Oral Administration of Gold Nanoparticles (AuNPs) on Knee Joint Health and Function
Interventions
Sponsor
4Life Research, LLC
Collaborators
Professional Athletic Orthopedics; St. Louis University
Start date
2020-08-03
Primary completion
2020-12-30
Sex
All
Age range
from 18 Years to 87 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * ≥ 18 and \<87 years of age * Having arthritis * Suffering from chronic knee pain * Failed treatments to date - including surgery, Physical Therapy, NSAIDs * Must agree to maintain the same eating, exercise, and sleep arrangements for the whole duration of the study Exclusion Criteria: * Having bacterial, intra-articular, or knee infections * Had any knee related partial or complete total knee replacement within 3 months prior to the start of the study * Had recent (3 months prior to start of the study) knee injection * Currently on NSAIDs * currently pregnant or lactating

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05347602